Suppr超能文献

校准与未校准基于动脉压的心输出量监测仪在原位肝移植中的比较。

Comparison of calibrated and uncalibrated arterial pressure-based cardiac output monitors during orthotopic liver transplantation.

机构信息

Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Liver Transpl. 2010 Jun;16(6):773-82. doi: 10.1002/lt.22056.

Abstract

Arterial pressure-based cardiac output monitors (APCOs) are increasingly used as alternatives to thermodilution. Validation of these evolving technologies in high-risk surgery is still ongoing. In liver transplantation, FloTrac-Vigileo (Edwards Lifesciences) has limited correlation with thermodilution, whereas LiDCO Plus (LiDCO Ltd.) has not been tested intraoperatively. Our goal was to directly compare the 2 proprietary APCO algorithms as alternatives to pulmonary artery catheter thermodilution in orthotopic liver transplantation (OLT). The cardiac index (CI) was measured simultaneously in 20 OLT patients at prospectively defined surgical landmarks with the LiDCO Plus monitor (CI(L)) and the FloTrac-Vigileo monitor (CI(V)). LiDCO Plus was calibrated according to the manufacturer's instructions. FloTrac-Vigileo did not require calibration. The reference CI was derived from pulmonary artery catheter intermittent thermodilution (CI(TD)). CI(V)-CI(TD) bias ranged from -1.38 (95% confidence interval = -2.02 to -0.75 L/minute/m(2), P = 0.02) to -2.51 L/minute/m(2) (95% confidence interval = -3.36 to -1.65 L/minute/m(2), P < 0.001), and CI(L)-CI(TD) bias ranged from -0.65 (95% confidence interval = -1.29 to -0.01 L/minute/m(2), P = 0.047) to -1.48 L/minute/m(2) (95% confidence interval = -2.37 to -0.60 L/minute/m(2), P < 0.01). For both APCOs, bias to CI(TD) was correlated with the systemic vascular resistance index, with a stronger dependence for FloTrac-Vigileo. The capability of the APCOs for tracking changes in CI(TD) was assessed with a 4-quadrant plot for directional changes and with receiver operating characteristic curves for specificity and sensitivity. The performance of both APCOs was poor in detecting increases and fair in detecting decreases in CI(TD). In conclusion, the calibrated and uncalibrated APCOs perform differently during OLT. Although the calibrated APCO is less influenced by changes in the systemic vascular resistance, neither device can be used interchangeably with thermodilution to monitor cardiac output during liver transplantation.

摘要

基于动脉压力的心输出量监测仪(APCO)越来越多地被用作热稀释法的替代品。这些不断发展的技术在高危手术中的验证仍在进行中。在肝移植中,FloTrac-Vigileo(爱德华生命科学公司)与热稀释法相关性有限,而 LiDCO Plus(LiDCO Ltd.)尚未在术中进行测试。我们的目标是直接比较这两种专有的 APCO 算法,作为替代肺动脉导管热稀释法在原位肝移植(OLT)中的应用。在 20 例 OLT 患者中,在预先确定的手术标志物处,同时使用 LiDCO Plus 监测仪(CI(L)) 和 FloTrac-Vigileo 监测仪(CI(V)))测量心指数(CI)。LiDCO Plus 根据制造商的说明进行校准。FloTrac-Vigileo 不需要校准。参考 CI 是从肺动脉导管间歇性热稀释法(CI(TD)))得出的。CI(V)-CI(TD)偏差范围从-1.38(95%置信区间= -2.02 至-0.75 L/minute/m(2),P=0.02)至-2.51 L/minute/m(2)(95%置信区间= -3.36 至-1.65 L/minute/m(2),P<0.001),CI(L)-CI(TD)偏差范围从-0.65(95%置信区间= -1.29 至-0.01 L/minute/m(2),P=0.047)至-1.48 L/minute/m(2)(95%置信区间= -2.37 至-0.60 L/minute/m(2),P<0.01)。对于这两种 APCO,与 CI(TD)的偏差与全身血管阻力指数相关,FloTrac-Vigileo 的依赖性更强。通过四象限图评估 APCO 跟踪 CI(TD)变化的能力,通过接收者操作特征曲线评估特异性和敏感性。这两种 APCO 检测 CI(TD)增加的性能都较差,检测减少的性能则较好。总之,校准和未校准的 APCO 在 OLT 期间表现不同。尽管校准后的 APCO 受全身血管阻力变化的影响较小,但在肝移植期间,这两种设备都不能与热稀释法交替使用来监测心输出量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验